{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:16:12Z","timestamp":1778156172801,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.clbc.2026.03.017","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:58:49Z","timestamp":1774630729000},"page":"140-153.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond Pathology: MRI-derived Metrics Unlock Preoperative Prognostic Risk Stratification in Breast Cancer"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7961-0631","authenticated-orcid":false,"given":"Mehrad","family":"Zare","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisa","family":"Mohebbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshin","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad","family":"Tavangar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clbc.2026.03.017_bib0001","first-page":"1","article-title":"Epidemiology and risk factors for breast cancer: 21st century advances, gaps to address through interdisciplinary science","volume":"13","author":"Terry","year":"2023","journal-title":"Cold Spring Harbor Persp Med"},{"issue":"3","key":"10.1016\/j.clbc.2026.03.017_bib0002","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/GRF.0000000000000721","article-title":"Breast cancer epidemiology and contemporary breast cancer care: a review of the literature and clinical applications","volume":"65","author":"El Masri","year":"2022","journal-title":"Clin Obstetr Gynecol"},{"issue":"3","key":"10.1016\/j.clbc.2026.03.017_bib0003","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: A Cancer J Clinicians"},{"issue":"2","key":"10.1016\/j.clbc.2026.03.017_bib0004","doi-asserted-by":"crossref","first-page":"C343","DOI":"10.1152\/ajpcell.00109.2021","article-title":"Heterogeneity within molecular subtypes of breast cancer","volume":"321","author":"Turner","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"10.1016\/j.clbc.2026.03.017_bib0005","first-page":"e7552","article-title":"Correlation between oncotype DX, PREDICT and the Nottingham Prognostic Index: implications for the management of early breast cancer","volume":"12","author":"Hillyar","year":"2020","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.clbc.2026.03.017_bib0006","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/bjc.1982.62","article-title":"A prognostic index in primary breast cancer","volume":"45","author":"Haybittle","year":"1982","journal-title":"Brit J Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2026.03.017_bib0007","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13643-018-0803-9","article-title":"Survival estimates stratified by the Nottingham Prognostic Index for early breast cancer: a systematic review and meta-analysis of observational studies","volume":"7","author":"Gray","year":"2018","journal-title":"System Rev"},{"issue":"2","key":"10.1016\/j.clbc.2026.03.017_bib0008","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10549-022-06729-7","article-title":"A comparative analysis of recurrence risk predictions in ER+\/HER2-\u2009early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast","volume":"196","author":"Gunda","year":"2022","journal-title":"Breast Cancer Res Treatm"},{"issue":"Suppl 1","key":"10.1016\/j.clbc.2026.03.017_bib0009","doi-asserted-by":"crossref","first-page":"P16","DOI":"10.1186\/bcr2968","article-title":"Preoperative estimation of the prognosis of invasive breast cancer, based on ultrasound size, core biopsy grade and percutaneous axillary lymph node biopsy","volume":"13","author":"Elseedawy","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2026.03.017_bib0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.mri.2024.02.012","article-title":"Prediction of the Nottingham prognostic index and molecular subtypes of breast cancer through multimodal magnetic resonance imaging","volume":"108","author":"Chen","year":"2024","journal-title":"Magn Resonance Imaging"},{"issue":"1","key":"10.1016\/j.clbc.2026.03.017_bib0011","article-title":"MRI as a biomarker for breast cancer diagnosis and prognosis","volume":"4","author":"Galati","year":"2022","journal-title":"BJR Open"},{"issue":"8","key":"10.1016\/j.clbc.2026.03.017_bib0012","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.crad.2017.10.021","article-title":"Clinical role of breast MRI now and going forward","volume":"73","author":"Leithner","year":"2018","journal-title":"Clin Radiol"},{"issue":"4","key":"10.1016\/j.clbc.2026.03.017_bib0013","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11912-023-01372-x","article-title":"Breast MRI: clinical indications, recommendations, and future applications in breast cancer diagnosis","volume":"25","author":"Wekking","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.clbc.2026.03.017_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1057841","article-title":"Multiparametric MRI radiomics fusion for predicting the response and shrinkage pattern to neoadjuvant chemotherapy in breast cancer","volume":"13","author":"Fan","year":"2023","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2026.03.017_bib0015","article-title":"Multiparametric MRI-based radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer","volume":"14","author":"Mohamed","year":"2024","journal-title":"Scient Rep"},{"key":"10.1016\/j.clbc.2026.03.017_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejro.2025.100665","article-title":"3.0 T multi-parametric MRI combined with clinical features improve malignancy prediction of BI-RADS 4 lesions and preoperative prediction of Nottingham Prognostic Index","volume":"14","author":"Zhou","year":"2025","journal-title":"Eur J Radiol Open"},{"issue":"6","key":"10.1016\/j.clbc.2026.03.017_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines13061364","article-title":"Role of preoperative breast MRI in predicting tumor-infiltrating lymphocytes in breast cancer: is there an association with tumor biological subtypes?","volume":"13","author":"Gigli","year":"2025","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.clbc.2026.03.017_bib0018","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41416-018-0185-8","article-title":"A machine learning approach to radiogenomics of breast cancer: a study of 922 subjects and 529 DCE-MRI features","volume":"119","author":"Saha","year":"2018","journal-title":"Brit J Cancer"},{"key":"10.1016\/j.clbc.2026.03.017_bib0019","article-title":"Dynamic contrast-enhanced magnetic resonance images of breast cancer patients with tumor locations (Version 3)","author":"Saha","year":"2021","journal-title":"Cancer Imaging Arch"},{"issue":"2","key":"10.1016\/j.clbc.2026.03.017_bib0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1308\/003588414X14055925060514","article-title":"The Nottingham Prognostic Index: five- and ten-year data for all-cause survival within a screened population","volume":"97","author":"Fong","year":"2015","journal-title":"Ann Royal Coll Surg Engl"},{"key":"10.1016\/j.clbc.2026.03.017_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1398922","article-title":"A nomogram with Nottingham prognostic index for predicting locoregional recurrence in breast cancer patients","volume":"14","author":"Zheng","year":"2024","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.clbc.2026.03.017_bib0022","first-page":"38","article-title":"[Impact of tumor size on actuarial survival of patients with primary breast sarcoma: a case-control study]","author":"Coloma","year":"2024","journal-title":"Khirurgiia"},{"issue":"11","key":"10.1016\/j.clbc.2026.03.017_bib0023","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1002\/cam4.1785","article-title":"Would 1.0 cm be a more suitable cutoff to subdivide pT1 tumors in hormone receptor-negative and HER2-positive breast cancer?","volume":"7","author":"Wang","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.clbc.2026.03.017_bib0024","article-title":"Tumor size still impacts prognosis in breast cancer with extensive nodal involvement","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.clbc.2026.03.017_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm13072021","article-title":"Traditional clinicopathological biomarkers still determine disease-free and overall survival in invasive breast cancer patients: a pilot study","volume":"13","author":"Wrzeszcz","year":"2024","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.clbc.2026.03.017_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr3570","article-title":"Mammographic density and risk of breast cancer by age and tumor characteristics","volume":"15","author":"Bertrand","year":"2013","journal-title":"Breast Cancer Res: BCR"},{"issue":"21","key":"10.1016\/j.clbc.2026.03.017_bib0027","first-page":"1","article-title":"Mammographic breast density at breast cancer diagnosis and breast cancer-specific survival","volume":"14","author":"Kanbayti","year":"2024","journal-title":"Diagnostics (Basel, Switzerland)"},{"key":"10.1016\/j.clbc.2026.03.017_bib0028","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1781762","article-title":"Exploring the role of breast density on cancer prognosis among women attending population-based screening programmes","volume":"2019","author":"Domingo","year":"2019","journal-title":"J Oncol"},{"issue":"1087","key":"10.1016\/j.clbc.2026.03.017_bib0029","article-title":"Breast cancer: influence of tumour volume estimation method at MRI on prediction of pathological response to neoadjuvant chemotherapy","volume":"91","author":"Henderson","year":"2018","journal-title":"Brit J Radiol"},{"issue":"6","key":"10.1016\/j.clbc.2026.03.017_bib0030","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.2214\/ajr.184.6.01841774","article-title":"MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival","volume":"184","author":"Partridge","year":"2005","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.clbc.2026.03.017_bib0031","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4174\/astr.2018.95.4.183","article-title":"Prognostic influence of 3-dimensional tumor volume on breast cancer compared to conventional 1-dimensional tumor size","volume":"95","author":"Hwang","year":"2018","journal-title":"Ann Surgic Treatm Res"},{"issue":"1","key":"10.1016\/j.clbc.2026.03.017_bib0032","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12880-025-01698-x","article-title":"Study on heterogeneity of vascularity and cellularity via multiparametric MRI habitat imaging in breast cancer","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Med Imaging"},{"issue":"1","key":"10.1016\/j.clbc.2026.03.017_bib0033","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12880-022-00908-0","article-title":"Quantitative DCE-MRI prediction of breast cancer recurrence following neoadjuvant chemotherapy: a preliminary study","volume":"22","author":"Thawani","year":"2022","journal-title":"BMC Med Imaging"},{"issue":"1","key":"10.1016\/j.clbc.2026.03.017_bib0034","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41523-021-00247-3","article-title":"Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis","volume":"7","author":"Xiao","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.clbc.2026.03.017_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1395502","article-title":"Initial experience in implementing quantitative DCE-MRI to predict breast cancer therapy response in a multi-center and multi-vendor platform setting","volume":"14","author":"Moloney","year":"2024","journal-title":"Front Oncol"},{"issue":"1119","key":"10.1016\/j.clbc.2026.03.017_bib0036","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200630","article-title":"Background parenchymal enhancement and breast cancer: a review of the emerging evidences about its potential use as imaging biomarker","volume":"94","author":"Rella","year":"2021","journal-title":"Brit J Radiol"},{"issue":"1","key":"10.1016\/j.clbc.2026.03.017_bib0037","article-title":"Quantitative background parenchymal enhancement to predict recurrence after neoadjuvant chemotherapy for breast cancer","volume":"9","author":"Moliere","year":"2019","journal-title":"Scient Rep"},{"issue":"8","key":"10.1016\/j.clbc.2026.03.017_bib0038","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/1759-7714.12774","article-title":"Axillary lymph node metastasis detection by magnetic resonance imaging in patients with breast cancer: a meta-analysis","volume":"9","author":"Zhou","year":"2018","journal-title":"Thorac Cancer"},{"issue":"3 Suppl","key":"10.1016\/j.clbc.2026.03.017_bib0039","doi-asserted-by":"crossref","first-page":"Ws1","DOI":"10.2214\/AJR.09.7213","article-title":"Indications for breast MRI: case-based review","volume":"196","author":"Argus","year":"2011","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.clbc.2026.03.017_bib0040","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4132\/jptm.2018.10.03","article-title":"The prognostic impact of synchronous ipsilateral multiple breast cancer: survival outcomes according to the Eighth American Joint Committee on Cancer Staging and Molecular Subtype","volume":"52","author":"Chu","year":"2018","journal-title":"J Pathol Transl Med"},{"issue":"12","key":"10.1016\/j.clbc.2026.03.017_bib0041","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/annonc\/mds136","article-title":"Multifocality and multicentricity in breast cancer and survival outcomes","volume":"23","author":"Lynch","year":"2012","journal-title":"Ann Oncol: Offic J Eur Soc Med Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2026.03.017_bib0042","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/tbj.12366","article-title":"Multifocal and multicentric breast cancer is associated with increased local recurrence regardless of surgery type","volume":"21","author":"Shaikh","year":"2015","journal-title":"Breast J"},{"key":"10.1016\/j.clbc.2026.03.017_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1042789","article-title":"Comparing the outcome between multicentric\/multifocal breast cancer and unifocal breast cancer: a systematic review and meta-analysis","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.clbc.2026.03.017_bib0044","first-page":"1","article-title":"Multiparametric MRI features of breast cancer molecular subtypes","volume":"58","author":"Szep","year":"2022","journal-title":"Medicina (Kaunas, Lithuania)"},{"key":"10.1016\/j.clbc.2026.03.017_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejro.2024.100585","article-title":"The association of magnetic resonance imaging features with five molecular subtypes of breast cancer","volume":"13","author":"Nguyen","year":"2024","journal-title":"Eur J Radiol Open"},{"issue":"1","key":"10.1016\/j.clbc.2026.03.017_bib0046","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4132\/jptm.2020.09.03","article-title":"Imaging features of breast cancer molecular subtypes: state of the art","volume":"55","author":"Cho","year":"2021","journal-title":"J Pathol Transl Med"},{"issue":"11","key":"10.1016\/j.clbc.2026.03.017_bib0047","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1007\/s00330-024-10805-5","article-title":"A predictive model using MRI and clinicopathologic features for breast cancer recurrence in young women treated with upfront surgery","volume":"34","author":"Chae","year":"2024","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.clbc.2026.03.017_bib0048","first-page":"303","article-title":"Does size matter? Comparison study between MRI, gross, and microscopic tumor sizes in breast cancer in lumpectomy specimens","volume":"3","author":"Behjatnia","year":"2010","journal-title":"Int J Clin Experiment Pathol"},{"issue":"7","key":"10.1016\/j.clbc.2026.03.017_bib0049","first-page":"391","article-title":"Accuracy of tumor size measurements performed by magnetic resonance, ultrasound and mammography, and their correlation with pathological size in primary breast cancer","volume":"97","author":"Cuesta","year":"2019","journal-title":"Cirugia Espanola"},{"issue":"1","key":"10.1016\/j.clbc.2026.03.017_bib0050","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1038\/s41598-020-60393-9","article-title":"Automated volumetric radiomic analysis of breast cancer vascularization improves survival prediction in primary breast cancer","volume":"10","author":"Dietzel","year":"2020","journal-title":"Scient Rep"},{"issue":"18","key":"10.1016\/j.clbc.2026.03.017_bib0051","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1088\/0031-9155\/56\/18\/014","article-title":"Computerized three-class classification of MRI-based prognostic markers for breast cancer","volume":"56","author":"Bhooshan","year":"2011","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.clbc.2026.03.017_bib0052","article-title":"Prediction of prognostic factors and genotypes in patients with breast cancer using multiple mathematical models of MR diffusion imaging","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926000492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926000492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:45:10Z","timestamp":1778154310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926000492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1526820926000492"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.03.017","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond Pathology: MRI-derived Metrics Unlock Preoperative Prognostic Risk Stratification in Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}